Lataa...
Increased platelet reactivity in dyslipidemic patients with coronary artery disease on dual anti-platelet therapy
INTRODUCTION: The optimal duration of dual anti-platelet therapy (DAPT) following percutaneous coronary intervention (PCI) is still a matter of debate. Biomarkers may help to identify patients who will benefit from extended DAPT. The aim of the study was to test the interaction between lipid paramet...
Tallennettuna:
| Julkaisussa: | Arch Med Sci |
|---|---|
| Päätekijät: | , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Termedia Publishing House
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6348363/ https://ncbi.nlm.nih.gov/pubmed/30697254 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/aoms.2018.81035 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|